Advertisement
Screener

SABBY MANAGEMENT, LLC Historic Quarter Change: USA Warrants, Sold Out

SABBY MANAGEMENT, LLC historic quarter change: USA Warrants, Sold out

In warrants (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, SABBY MANAGEMENT, LLC opened 31 positions, added to 19, reduced 28 and sold out of 19.

  • Q4 2024: Stock WEARABLE DEVICES LTD; Country of operation —; Class *W; Shares before 148,717.
  • Q1 2024: Stock BRUUSH ORAL CARE INC; Country of operation —; Class *W; Shares before 177,542.
  • Q3 2016: Stock KITOV PHARMACEUTICALS HOLDINGS; Country of operation —; Class *W; Shares before 1,210,785.
  • Q3 2016: Stock RENNOVA HEALTH INC; Country of operation —; Class *W; Shares before 3,225,806.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1535610), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-18); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2024WEARABLE DEVICES LTD
CUSIP M97838110
*W148,7170-148,717$2,959$0-$2,9592025-02-14
Q1 2024BRUUSH ORAL CARE INC
CUSIP 11750K120
*W177,5420-177,542$1,207$0-$1,2072024-05-15
Q3 2016KITOV PHARMACEUTICALS HOLDINGS
CUSIP 49803V115
*W1,210,7850-1,210,785$944,000$0-$944,0002016-11-14
Q3 2016RENNOVA HEALTH INC
CUSIP 759757115
*W3,225,8060-3,225,806$32,000$0-$32,0002016-11-14
Q2 2016MEDGENICS EQUITY WARRANTS EXP 13 FEB 2018
CUSIP 58436Q112
*W1,564,3700-1,564,370$1,173,000$0-$1,173,0002016-08-15
Q2 2016SYNERGY PHARMACEUTICALS EQUITY WARRANTS
CUSIP 871639118
*W285,4140-285,414$157,000$0-$157,0002016-08-15
Q2 2016PERSEON EQUITY WARRANTS
CUSIP 715270112
*W1,887,8920-1,887,892$4,000$0-$4,0002016-08-15
Q2 2016OPEXA THERAPEUTICS EQUITY WARRANTS
CUSIP 68372T129
*W34,0970-34,097$2,000$0-$2,0002016-08-15
Q1 2016CELLECTAR BIOSCIENCES INC
CUSIP 15117F112
*W653,7120-653,712$365,000$0-$365,0002016-05-13
Q1 2016OPEXA THERAPEUTICS EQUITY WARRANTS 03/13/201
CUSIP 68372T202
*W99,2680-99,268$10,000$0-$10,0002016-05-13
Q4 2015NEUROMETRIX EQUITY WARRANTS
CUSIP 641255138
*W12,212,2780-12,212,278$3,052,000$0-$3,052,0002016-02-16
Q4 2015APPLIED DNA SCIENCES EQUITY WARRANTS
CUSIP 03815U110
*W63,3100-63,310$196,000$0-$196,0002016-02-16
Q4 2015OPEXA THERAPEUTICS EQUITY WARRANTS
CUSIP 68372T129
*W382,7650-382,765$46,000$0-$46,0002016-02-16
Q3 2015CEL SCI EQUITY WARRANTS
CUSIP 150837177
*W1,845,8410-1,845,841$369,000$0-$369,0002015-11-16
Q3 2015PROVECTUS BIOPHARMACEUTICALS EQUITY WARRANTS
CUSIP 74373P116
*W749,3370-749,337$164,000$0-$164,0002015-11-16
Q2 2015PLASMATECH BIOPHARMACEUTICALS
CUSIP 72754H117
*W986,1750-986,175$838,000$0-$838,0002015-08-14
Q1 2015MEDGENICS INC-CW18
CUSIP 58436Q112
*W1,271,2400-1,271,240$922,000$0-$922,0002015-05-15
Q3 2014QUINPARIO ACQUISITION - CW18
CUSIP 74874R116
*W60,4000-60,400$82,000$0-$82,0002014-11-18
Q3 2014ADVAXIS INC-CW18
CUSIP 007624117
*W45,3540-45,354$46,000$0-$46,0002014-11-18

Similar Firms

Firm NameCountry13F ValueHoldings
NOVUS ADVISORS, LLCUnited States$0.045B47
Circumference Group LLCUnited States$0.045B13
Israel Discount Bank of New YorkUnited States$0.046B43
OPTIMAS CAPITAL LtdHong Kong$0.045B11
INVESTMENT COUNSEL CO OF NEVADAUnited States$0.044B99
Prentice Capital Management, LPUnited States$0.046B23
CTC Alternative Strategies, Ltd.United States$0.044B96
Crestline Management, L.P.United States$0.046B3
Matrix Capital Management Company, LPUnited States$0.046B1
Miura Global Management, LLCUnited States$0.044B15